Optimizing outcomes in major depressive disorder via augmentation therapy--focus on the role of atypical antipsychotics. Foreword

CNS Drugs. 2013 May:27 Suppl 1:S3-4. doi: 10.1007/s40263-012-0027-9.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Depressive Disorder, Major / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Practice Guidelines as Topic
  • Treatment Outcome

Substances

  • Antipsychotic Agents